Similarly, in different grades, anti-AKAP4 antibodies were detected in majority of grade 1 (77%), grade 2 (81%) and grade 3 (88%) cancer patients with mean titers of 0.66±0.05, 0.80±0.08, and 0.63±0.08 respectively (Figure S3B). This evidence concerns the gene AKAP4 and cancer.